Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Huck

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of the American Chemical Society|January 19, 2021
Synthetic Studies on Selective, Proapoptotic Isomalabaricane Triterpenoids Aided by Computational TechniquesYaroslav D Boyko, Christopher J Huck, Shang Ning, et al.
Journal of the American Chemical Society|July 28, 2021
Correction to "Synthetic Studies on Selective, Proapoptotic Isomalabaricane Triterpenoids Aided by Computational Techniques"Yaroslav D Boyko, Christopher J Huck, Shang Ning, et al.
The Science of the Total Environment|October 23, 2024
Surface-derived groundwater contamination in Gulu District, Uganda: Chemical and microbial tracersGeorge J L Wilson, Derick Muloogi, Rajabu Hamisi, et al.
Journal of Inherited Metabolic Disease|May 7, 2005
A newborn with severe liver failure, cardiomyopathy and transaldolase deficiencyN M Verhoeven, M Wallot, J H J Huck, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 21, 2005
Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillationsThomas Klausberger, Laszlo F Marton, Joseph O'Neill, et al.
Molecular Cancer Therapeutics|July 2, 2014
Translational exposure-efficacy modeling to optimize the dose and schedule of taxanes combined with the investigational Aurora A kinase inhibitor MLN8237 (alisertib)Jessica J Huck, Mengkun Zhang, Jerome Mettetal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2011
Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assaysMark G Manfredi, Jeffrey A Ecsedy, Arijit Chakravarty, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinaseMark G Manfredi, Jeffrey A Ecsedy, Kristan A Meetze, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of the American Chemical Society|January 19, 2021
Synthetic Studies on Selective, Proapoptotic Isomalabaricane Triterpenoids Aided by Computational TechniquesYaroslav D Boyko, Christopher J Huck, Shang Ning, et al.
Journal of the American Chemical Society|July 28, 2021
Correction to "Synthetic Studies on Selective, Proapoptotic Isomalabaricane Triterpenoids Aided by Computational Techniques"Yaroslav D Boyko, Christopher J Huck, Shang Ning, et al.
The Science of the Total Environment|October 23, 2024
Surface-derived groundwater contamination in Gulu District, Uganda: Chemical and microbial tracersGeorge J L Wilson, Derick Muloogi, Rajabu Hamisi, et al.
Journal of Inherited Metabolic Disease|May 7, 2005
A newborn with severe liver failure, cardiomyopathy and transaldolase deficiencyN M Verhoeven, M Wallot, J H J Huck, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 21, 2005
Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillationsThomas Klausberger, Laszlo F Marton, Joseph O'Neill, et al.
Molecular Cancer Therapeutics|July 2, 2014
Translational exposure-efficacy modeling to optimize the dose and schedule of taxanes combined with the investigational Aurora A kinase inhibitor MLN8237 (alisertib)Jessica J Huck, Mengkun Zhang, Jerome Mettetal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2011
Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assaysMark G Manfredi, Jeffrey A Ecsedy, Arijit Chakravarty, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinaseMark G Manfredi, Jeffrey A Ecsedy, Kristan A Meetze, et al.
Pageof 5